SB 2933

Hawaii Senate bill in Session 2026.

Status: failed. Latest action: February 18, 2026.

DOH; Insurance Commissioner; Health Care; Costs; Prescription Drug Affordability Board; Upper Payment Limits; Out-of-Pocket Maximums; Copayment Adjustment Programs; Reports; Rules; Appropriation.

Bill ID HI-2026-SB-2933
Session 2026
Status failed
Committee HHS/CPN, WAM/JDC
Senate failed 2026-02-18
Summary

Establishes the Prescription Drug Affordability Board within the Department of Health to conduct affordability reviews on high-cost prescription drugs and establish upper payment limits under certain circumstances. Establishes out-of-pocket maximums for prescribed insulin, asthma inhalers, and epinephrine auto-injectors. Prohibits copayment adjustment programs. Requires health insurers, mutual benefit societies, and health maintenance organizations to comply with certain affordability measures. Requires annual reports to the Legislature. Requires adoption of rules by the Affordability Board and Insurance Commissioner. Appropriates funds.

Sponsor
Angus L.K. McKelvey
Official Source Back to Bills
Actions Timeline
Date Event Detail
0000-00-00 Introduced Bill introduced
2026-02-18 Status failed
2026-02-18 Latest Action The committee on CPN deferred the measure.
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States